Cite
Bredemeier M, Ranza R, Kakehasi AM, et al. Safety of the Methotrexate-leflunomide Combination in Rheumatoid Arthritis: Results of a Multicentric, Registry-based, Cohort Study (BiobadaBrasil). J Rheumatol. 2022;49(1):122doi: 10.3899/jrheum.201248.C1.
Bredemeier, M., Ranza, R., Kakehasi, A. M., Ranzolin, A., da Silveira, I. G., Ribeiro, A. C. M., Titton, D. C., Hayata, A. L. S., Carvalho, H. M. S., Kahlow, B. S., Fernandes, V., Louzada, P., Bértolo, M. B., Duarte, �. �. L. B. P., Macieira, J. C., Miranda, J. R. S., Pinheiro, G. R. C., Teodoro, R. B., Pinheiro, M. M., Valim, V., Pereira, I. A., Sauma, M. F. L. C., de Castro, G. R. W., da Rocha, L. F., Studart, S. A. S., Gazzeta, M. O., da Silveira, L. G., Lupo, C. M., & Laurindo, I. M. M. (2022). Safety of the Methotrexate-leflunomide Combination in Rheumatoid Arthritis: Results of a Multicentric, Registry-based, Cohort Study (BiobadaBrasil). The Journal of rheumatology, 49(1), 122. https://doi.org/10.3899/jrheum.201248.C1
Bredemeier, Markus, et al. "Safety of the Methotrexate-leflunomide Combination in Rheumatoid Arthritis: Results of a Multicentric, Registry-based, Cohort Study (BiobadaBrasil)." The Journal of rheumatology vol. 49,1 (2022): 122. doi: https://doi.org/10.3899/jrheum.201248.C1
Bredemeier M, Ranza R, Kakehasi AM, Ranzolin A, da Silveira IG, Ribeiro ACM, Titton DC, Hayata ALS, Carvalho HMS, Kahlow BS, Fernandes V, Louzada P, Bértolo MB, Duarte ÂLBP, Macieira JC, Miranda JRS, Pinheiro GRC, Teodoro RB, Pinheiro MM, Valim V, Pereira IA, Sauma MFLC, de Castro GRW, da Rocha LF, Studart SAS, Gazzeta MO, da Silveira LG, Lupo CM, Laurindo IMM. Safety of the Methotrexate-leflunomide Combination in Rheumatoid Arthritis: Results of a Multicentric, Registry-based, Cohort Study (BiobadaBrasil). J Rheumatol. 2022 Jan;49(1):122. doi: 10.3899/jrheum.201248.C1. PMID: 34974425.
Copy
Download .nbib